Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schühlen H, Dirschinger J, Berger PB, Schömig A; Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Kastrati A, et al. Among authors: schomig a. JAMA. 2006 Apr 5;295(13):1531-8. doi: 10.1001/jama.295.13.joc60034. Epub 2006 Mar 13. JAMA. 2006. PMID: 16533938 Clinical Trial.
Long-term outcome after coronary stenting.
Kastrati A, Hall D, Schömig A. Kastrati A, et al. Among authors: schomig a. Curr Control Trials Cardiovasc Med. 2000;1(1):48-54. doi: 10.1186/cvm-1-1-048. Curr Control Trials Cardiovasc Med. 2000. PMID: 11714409 Free PMC article.
Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).
Hausleiter J, Kastrati A, Mehilli J, Dotzer F, Schühlen H, Dirschinger J, Schömig A; ISAR-SMART Trail investigators. Hausleiter J, et al. Among authors: schomig a. Am J Cardiol. 2002 Jan 1;89(1):58-60. doi: 10.1016/s0002-9149(01)02164-6. Am J Cardiol. 2002. PMID: 11779524 Clinical Trial. No abstract available.
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schömig A; Stent versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction (STOPAMI-2) Study. Kastrati A, et al. Among authors: schomig a. Lancet. 2002 Mar 16;359(9310):920-5. doi: 10.1016/S0140-6736(02)08022-4. Lancet. 2002. PMID: 11918909 Clinical Trial.
Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy.
Dong J, Ndrepepa G, Schmitt C, Mehilli J, Schmieder S, Schwaiger M, Schömig A, Kastrati A. Dong J, et al. Among authors: schomig a. Circulation. 2002 Jun 25;105(25):2946-9. doi: 10.1161/01.cir.0000022604.56986.ff. Circulation. 2002. PMID: 12081985 Clinical Trial.
701 results